Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000381867 | SCV000336746 | benign | not specified | 2015-11-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000553082 | SCV000657743 | benign | Charcot-Marie-Tooth disease type 2 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173619 | SCV001336719 | benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000381867 | SCV002622333 | likely benign | not specified | 2020-08-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001701838 | SCV005041863 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | KIF1B: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV001701838 | SCV005287633 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001701838 | SCV001930617 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001701838 | SCV001954743 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003930094 | SCV004748506 | benign | KIF1B-related disorder | 2019-06-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |